Get started
Author

Monica Rutigliano

Observed names: M Rutigliano, M. Rutigliano, Rutigliano Monica, Rutigliano, Monica
ORCID: 0000-0001-9795-3585
Observed ORCID: 0000-0001-9795-3585
OpenAlex ID: A5055913929
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
2015 · Giuseppe Lucarelli, Vanessa Galleggiante, et al. · Oncotarget · 250
PDF
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
2018 · Giuseppe Lucarelli, Monica Rutigliano, et al. · Aging · 239
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
2022 · Nicola Antonio di Meo, Francesco Lasorsa, et al. · International Journal of Molecular Sciences · 190
PDF
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
2017 · Giuseppe Lucarelli, Monica Rutigliano, et al. · Urologic Oncology Seminars and Original Investigations · 159
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
2023 · Francesco Lasorsa, Nicola Antonio di Meo, et al. · Biomedicines · 154
PDF
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics
2016 · Rosa Ragone, Fabio Sallustio, et al. · Diseases · 144
PDF
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment
2019 · Roberto Tamma, Monica Rutigliano, et al. · Urologic Oncology Seminars and Original Investigations · 142
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
2023 · Nicola Antonio di Meo, Francesco Lasorsa, et al. · Expert Review of Molecular Diagnostics · 140
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
2023 · Francesco Lasorsa, Monica Rutigliano, et al. · Journal of Clinical Medicine · 131
PDF
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
2022 · Giuseppe Lucarelli, Monica Rutigliano, et al. · International Journal of Molecular Sciences · 119
PDF
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
2012 · Giuseppe Lucarelli, Margherita Fanelli, et al. · The Prostate · 104
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
2023 · Francesco Lasorsa, Monica Rutigliano, et al. · International Journal of Molecular Sciences · 103
PDF
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
2023 · Giuseppe Lucarelli, Giuseppe Stefano Netti, et al. · International Journal of Molecular Sciences · 102
PDF
Spondin-2, a Secreted Extracellular Matrix Protein, is a Novel Diagnostic Biomarker for Prostate Cancer
2013 · Giuseppe Lucarelli, Monica Rutigliano, et al. · The Journal of Urology · 85
Ischemia–Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets
2024 · Francesco Lasorsa, Monica Rutigliano, et al. · International Journal of Molecular Sciences · 81
PDF
The Role of MUC1 in Renal Cell Carcinoma
2024 · Martina Milella, Monica Rutigliano, et al. · Biomolecules · 72
PDF
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
2017 · Massimo Papale, Grazia Vocino, et al. · Oncotarget · 72
PDF
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
2015 · Giuseppe Lucarelli, Monica Rutigliano, et al. · Expert Review of Molecular Diagnostics · 72
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma
2015 · Giuseppe Lucarelli, Monica Rutigliano, et al. · Medicine · 69
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
2023 · Francesco Lasorsa, Monica Rutigliano, et al. · International Journal of Molecular Sciences · 68
PDF
Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy
2014 · Giuseppe Lucarelli, Vito Mancini, et al. · BioMed Research International · 66
PDF
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
2022 · Davide Loizzo, Savio Domenico Pandolfo, et al. · International Journal of Molecular Sciences · 65
PDF
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
2022 · Nicola Antonio di Meo, Davide Loizzo, et al. · International Journal of Molecular Sciences · 62
PDF
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
2023 · Francesco Lasorsa, Nicola Antonio di Meo, et al. · International Journal of Molecular Sciences · 61
PDF
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update
2019 · Giuseppe Lucarelli, Davide Loizzo, et al. · Expert Review of Molecular Diagnostics · 60
Works count: 81
Citation count: 3,561
H-index: 36
I10-index: 44
Year
Topic
Type